Cargando…
Novel Mechanisms and Future Opportunities for the Management of Radiation Necrosis in Patients Treated for Brain Metastases in the Era of Immunotherapy
SIMPLE SUMMARY: As the incidence and survival of patients with brain metastases improve, the burden of treatment-related neurotoxicities will increase for patients and healthcare systems. Radiation necrosis, or injury and inflammation to normal brain tissue, is an increasingly common and deleterious...
Autores principales: | Vaios, Eugene J., Winter, Sebastian F., Shih, Helen A., Dietrich, Jorg, Peters, Katherine B., Floyd, Scott R., Kirkpatrick, John P., Reitman, Zachary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177360/ https://www.ncbi.nlm.nih.gov/pubmed/37173897 http://dx.doi.org/10.3390/cancers15092432 |
Ejemplares similares
-
MMAP-07 IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
por: Vaios, Eugene, et al.
Publicado: (2022) -
Clinical Factors Associated With 30-Day Mortality Among Patients Undergoing Radiation Therapy for Brain Metastases
por: Natesan, Divya, et al.
Publicado: (2023) -
Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022) -
Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022) -
RADI-09. Clinical factors associated with death after radiotherapy for brain metastases
por: Natesan, Divya, et al.
Publicado: (2021)